Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.
暂无分享,去创建一个
K. Do | H. Kantarjian | G. Garcia-Manero | J. Cortes | M. Keating | S. O'brien | J. Burger | Xuemei Wang | W. Wierda | S. Faderl | A. Ferrajoli | S. Lerner | C. Koller | D. Thomas